Physician profile
Scott D Shapiro
NPI 1902967961
$4,166.99
in general payments reported to CMS, 2019-2025
33 companies · $1,690 in 2025
The $1,690 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $214 · 2021: $150 · 2022: $225 · 2023: $874 · 2024: $725 · 2025: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,575 · Travel and Lodging: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,574.64 |
| Travel and Lodging | $713.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,499.66 | 2019-2025 | Aveir, Ensite |
| Amgen INC. | $466.15 | 2022-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $356.69 | 2022-2025 | Camzyos, Eliquis |
| Kerecis Limited | $221.48 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Philips North America LLC | $219.53 | 2022-2025 | (Ck7) Extended Holter, (Ck4) Mcot, Extended Holter |
| Janssen Pharmaceuticals, INC | $162.09 | 2022-2024 | Xarelto |
| Baxter Healthcare | $159.37 | 2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Medicomp INC | $132.02 | 2024-2025 | Telepatch Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $118.44 | 2022-2025 | |
| Esperion Therapeutics, INC. | $117.12 | 2020-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $77.64 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $66.24 | 2024-2025 | Farxiga |
| Alnylam Pharmaceuticals INC. | $65.39 | 2025 | Amvuttra |
| Abbvie INC. | $55.59 | 2023-2025 | Synthroid |
| Novo Nordisk INC | $51.02 | 2022-2025 | Ozempic, Rybelsus |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $49.66 | 2024 | Bodyguardian |
| Actelion Pharmaceuticals US, INC. | $40.23 | 2023 | Opsumit |
| Biosense Webster, INC. | $29.29 | 2022 | |
| Bardy Diagnostics, INC. | $28.30 | 2020-2021 | |
| Celgene Corporation | $24.61 | 2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.38 | 2023 | Lifevest |
| Medtronic Vascular, INC. | $24.10 | 2019 | |
| Merck Sharp & Dohme LLC | $20.90 | 2023 | Verquvo |
| Terumo Medical Corporation | $20.38 | 2023 | Glidewire |
| Irhythm Technologies, INC. | $20.05 | 2024 | Zio Monitor, Zio Xt Patch |
| Glaxosmithkline, LLC. | $18.54 | 2025 | Shingrix |
| Scpharmaceuticals INC. | $16.17 | 2023 | |
| Idorsia Pharmaceuticals US INC | $15.66 | 2023 | Quviviq |
| Itamar Medical INC | $13.91 | 2023 | Watchpatone |
| Bridgebio Pharma, INC. | $13.73 | 2025 | Attruby |
| Medtronic, INC. | $13.24 | 2024 | Mycarelink |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.14 | 2022 | |
| Hikma Pharmaceuticals USA | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.